background image

S&P 500: 2024 Stars, Flops, and What's Hot for 2025!

Charu Chanana 400x400
Charu Chanana

Chief Investment Strategist

As 2024 ends, US equities have had a stellar year, with the S&P 500 delivering a 24% return in USD terms. Diving deeper into the index, the biggest winners and losers tell a story of significant market trends and investment themes that will likely remain relevant into 2025.

Top Performers of 2024

  • Artificial Intelligence Leads the Charge: AI continues to dominate as one of the most significant investment themes, propelling stocks like NVIDIA and Palantir to the top.
    • NVIDIA: Built on its 2023 gains, fueled by unprecedented demand for AI chips.
    • Palantir: Benefited from its enterprise AI solutions, filling unique technology niches.
    • Broadcom: Benefited from expectations of robust AI revenue growth given its differentiated chip design capabilities for high-performance networking and computing that is making it take market share from Nvidia.
  • Energy and Utilities Shine: The push for renewable energy and nuclear power has created immense value in the utility sector.
    • Vistra: Thrived on strong cash flow and renewable energy investments.
    • GE Vernova: Benefited from the renewed focus on nuclear energy as part of the clean energy transition.
  • Defense and Security Make a Comeback: Geopolitical tensions and rising defense budgets boosted stocks in the defense sector.
    • Axon Enterprise: Leveraged higher demand for public safety technology, including TASERs and body cameras.
    • Howmet Aerospace: Played a pivotal role in supplying critical components for military aircraft.
  • Oil and Gas Expansion: Traditional energy had a resurgence, especially in regions like the Permian Basin.
    • Targa Resources and Texas Pacific Land: Both saw strong growth from expanding oil and gas production under the “drill baby drill” narrative.
23_CHCA_Top
Source: Bloomberg, Saxo

Worst Performers of 2024

Not all sectors participated in the rally, as challenges in healthcare, retail, and semiconductors weighed on several stocks.

  • Healthcare Sector Struggles: The healthcare industry faced significant headwinds, with regulatory changes and shifting market dynamics impacting major players.
    • Walgreens Boots Alliance: Struggled with declining foot traffic and increased competition from online pharmacies, leading to a substantial drop in stock value.
    • Moderna: Faced challenges in sustaining growth after the initial success of its COVID-19 vaccines, leading to a significant stock decrease.
    • CVS Health: Faced challenges in adapting to new healthcare models and competitive pressures, resulting in a notable decline in its stock performance.
    • Humana: Experienced a downturn due to increased competition and regulatory uncertainties affecting its healthcare services.
  • Retail Sector Challenges: Economic uncertainties and changing consumer behaviors have taken a toll on retail giants.
    • Dollar Tree: Encountered difficulties in maintaining profitability amidst rising operational costs and shifting consumer preferences.
    • Dollar General: Suffered from economic pressures and a decrease in consumer spending, leading to a significant drop in stock value.
    • Estee Lauder Companies: Faced supply chain disruptions and changing consumer habits, impacting its stock performance negatively.
  • Technology Competition: Some tech firms like Intel struggled to maintain momentum post-pandemic due to the technological shifts in the semiconductor industry, resulting in a steep decline.
  • Energy Transition: High interest rates continued to make the operating environment difficult for renewable energy companies like Enphase Energy.
  • Broader Economic Slowdown: Weakness in auto and industrial sector demand weighed on Celanese.
23_CHCA_Bottom
Source: Bloomberg, Saxo

Investment Themes and Takeaways for 2025

  1. AI Remains a Megatrend: The AI boom is far from over. High valuations in NVIDIA and Palantir reflect investor expectations for sustained growth.
    1. Subthemes such as increased energy needs for data centers will drive opportunities in utilities and clean energy.
    2. NVIDIA thrived due to AI-driven demand, while Intel (-62%) struggled amid reduced consumer electronics sales and competition from companies like Apple making their own chips. This divergence reflects the “elimination race” in the semiconductor space.
  2. Clean Energy & Utilities Are Crucial: The transition to renewables and nuclear energy continues to drive significant returns.
    1. Companies like Vistra and GE Vernova highlight a derived sub-theme—AI’s energy-intensive infrastructure is boosting utilities, particularly those invested in nuclear power.
  3. Defense Spending on the Rise: Global geopolitical tensions make defense and security a critical investment area.
  4. Energy Expansion Is Back: Traditional energy remains vital, with oil and gas companies capitalizing on expanded production opportunities. The “drill baby drill” narrative and US energy independence push suggest ongoing opportunities in traditional energy.
  5. Healthcare May Be Poised for Recovery: Despite current pressures from rising costs and regulatory risks, healthcare remains ripe for growth through defensive strategies and innovations in AI, obesity, and cancer therapies, offering long-term investment opportunities.
  6. Consumer Sector Divergence: The US consumer market is experiencing a shift, with trading down trends becoming more prevalent. This divergence in retail trends presents both challenges and opportunities, as some retailers adapt to changing consumer preferences while others struggle to maintain market share.

Outrageous Predictions 2026

01 /

  • Executive Summary: Outrageous Predictions 2026

    Outrageous Predictions

    Executive Summary: Outrageous Predictions 2026

    Saxo Group

    Read Saxo's Outrageous Predictions for 2026, our latest batch of low probability, but high impact ev...
  • A Fortune 500 company names an AI model as CEO

    Outrageous Predictions

    A Fortune 500 company names an AI model as CEO

    Charu Chanana

    Chief Investment Strategist

    Can AI be trusted to take over in the boardroom? With the right algorithms and balanced human oversi...
  • Dollar dominance challenged by Beijing’s golden yuan

    Outrageous Predictions

    Dollar dominance challenged by Beijing’s golden yuan

    Charu Chanana

    Chief Investment Strategist

    Beijing does an end-run around the US dollar, setting up a framework for settling trade in a neutral...
  • Dumb AI triggers trillion-dollar clean-up

    Outrageous Predictions

    Dumb AI triggers trillion-dollar clean-up

    Jacob Falkencrone

    Global Head of Investment Strategy

    Agentic AI systems are deployed across all sectors, and after a solid start, mistakes trigger a tril...
  • Quantum leap Q-Day arrives early, crashing crypto and destabilizing world finance

    Outrageous Predictions

    Quantum leap Q-Day arrives early, crashing crypto and destabilizing world finance

    Neil Wilson

    Investor Content Strategist

    A quantum computer cracks today’s digital security, bringing enough chaos with it that Bitcoin crash...
  • SpaceX announces an IPO, supercharging extraterrestrial markets

    Outrageous Predictions

    SpaceX announces an IPO, supercharging extraterrestrial markets

    John J. Hardy

    Global Head of Macro Strategy

    Financial markets go into orbit, to the moon and beyond as SpaceX expands rocket launches by orders-...
  • Taylor Swift-Kelce wedding spikes global growth

    Outrageous Predictions

    Taylor Swift-Kelce wedding spikes global growth

    John J. Hardy

    Global Head of Macro Strategy

    Next year’s most anticipated wedding inspires Gen Z to drop the doomscrolling and dial up the real w...
  • Britain’s Great EU Backdoor Return

    Outrageous Predictions

    Britain’s Great EU Backdoor Return

    Neil Wilson

    Investor Content Strategist

    Faced with rolling fiscal, economic, trade and political crises the UK government sneaks back into t...
  • Obesity drugs for everyone – even for pets

    Outrageous Predictions

    Obesity drugs for everyone – even for pets

    Jacob Falkencrone

    Global Head of Investment Strategy

    The availability of GLP-1 drugs in pill form makes them ubiquitous, shrinking waistlines, even for p...
  • Despite concerns, U.S. 2026 mid-term elections proceed smoothly

    Outrageous Predictions

    Despite concerns, U.S. 2026 mid-term elections proceed smoothly

    John J. Hardy

    Global Head of Macro Strategy

    In spite of outstanding threats to the American democratic process, the US midterms come and go cord...

This content is marketing material. 

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Market Ltd. (SCML) provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice or a recommendation.

SCML content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

SCML partners with companies that provide compensation for promotional activities conducted on its platform. Some partners also pay retrocessions contingent on clients investing in products from those partners. 

While SCML receives compensation from these partnerships, all educational and research content remains focused on providing information to clients.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. SCML does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992